The Necroptosis Pathway Is Upregulated in the Cornea in Mice With Ocular Graft-Versus-Host Disease-Reference-Cited by-同舟云学术

The Necroptosis Pathway Is Upregulated in the Cornea in Mice With Ocular Graft-Versus-Host Disease

Published:2024-08-27 Issue:10 Volume:65 Page:38
ISSN:1552-5783
Container-title:Investigative Ophthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Asai Kazuki¹,Lee Hyung Keun²,Sato Shinri¹,Shimizu Eisuke¹,Jung Jaehun²,Okazaki Takahiro¹,Ogawa Mamoru¹,Shimmura Shigeto¹³,Tsubota Kazuo¹⁴,Ogawa Yoko¹,Negishi Kazuno¹,Hirayama Masatoshi¹

Affiliation:

1. Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan

2. Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea

3. Department of Clinical Regenerative Medicine, Fujita Health University, Tokyo, Japan

4. Tsubota Laboratory, Inc., Tokyo, Japan

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Reference84 articles.

1. Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT;Inamoto;Bone Marrow Transplant,2019

2. Graft versus host disease: clinical evaluation, diagnosis and management;Espana;Graefes Arch Clin Exp Ophthalmol,2013

3. Dry eye after haematopoietic stem cell transplantation;Ogawa;Br J Ophthalmol,1999

4. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects;Tichelli;Bone Marrow Transplant,1996

5. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly Morbid Forms Report;Wolff;Transplant Cell Ther,2021